Article
Specifically engineered for once-daily, non-antibiotic treatment of the inflammatory lesions of rosacea.
In this Dermatology Times supplement, a group of experts in the management and treatment of rosacea discuss the clinical impact of the latest findings regarding understanding of the pathophysiology of the disease, as well as commonly-used therapeutic agents and drug combinations that may be effective in treatment-specific rosacea symptoms.
Learning objectives:
Download Supplement
Lisette Hilton
Lisette Hilton
Lisette Hilton
John Jesitus
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.